Related Experiment Video
Updated: Jul 14, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement
Buu-Khanh Lam1, Vincent Chan, Paul Hendry
1Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. bklam@ottawaheart.ca
Objectives:
The incidence of patient-prosthesis mismatch after mitral valve replacement and its effect on late outcomes have remained unclear. This study was conducted to determine the impact of patient-prosthesis mismatch on recurrent congestive heart failure, postoperative pulmonary hypertension, and late survival after mitral valve replacement.
Methods:
Between 1985 and 2005, 884 patients, with a mean age 63 +/- 12 years, underwent mitral valve replacement (657 mechanical, 227 bioprosthesis) with contemporary prostheses. Mean clinical and echocardiographic follow-up was 5.1 +/- 4.1 years (4344 patient-years). Patient-prosthesis mismatch was defined as an indexed effective orifice area of 1.25 cm2/m2 or less. Parametric and nonparametric analyses were used to determine predictors of outcomes.
Results:
The incidence of patient-prosthesis mismatch was 32%. Predictors of recurrent congestive heart failure included low indexed effective orifice area, low ejection fraction, elevated postoperative mean mitral gradient, and use of a bioprosthesis (P < or = .05). Postoperative pulmonary hypertension was associated with small mitral size, elevated mean mitral gradient, low ejection fraction, and atrial fibrillation (P < or = .05); indexed effective orifice area did not predict postoperative pulmonary hypertension (P = .89). Poor late survival was predicted by low indexed effective orifice area (< or =1.25 cm2/m2), New York Heart Association class 3 or 4, elevated right ventricular pressure, stroke, older age, coronary artery disease, and bioprosthesis use (P < or = .05). Survival for patients with patient-prosthesis mismatch versus those without patient-prosthesis mismatch at 1, 3, 5, and 10 years was 91% versus 95%, 85% versus 90%, 78% versus 86%, and 65% versus 75%, respectively (P = .05).
Conclusions:
Patient-prosthesis mismatch after mitral valve replacement is not uncommon; it is associated with recurrence of congestive heart failure and postoperative pulmonary hypertension and independently affected late survival. This study emphasizes the importance of implanting a sufficiently large prosthesis in adult patients undergoing mitral valve replacement.
Insights
Patient-prosthesis mismatch after mitral valve replacement is common and linked to heart failure and pulmonary hypertension. Choosing a larger prosthesis improves long-term survival for patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Patient-prosthesis mismatch (PPM) after mitral valve replacement (MVR) is a concern.
- Its impact on long-term outcomes like heart failure, pulmonary hypertension, and survival remains unclear.
Purpose of the Study:
- To determine the incidence of PPM after MVR.
- To assess the effect of PPM on recurrent congestive heart failure, postoperative pulmonary hypertension, and late survival.
Main Methods:
- Retrospective analysis of 884 patients undergoing MVR (1985-2005).
- PPM defined as indexed effective orifice area ≤ 1.25 cm²/m².
- Clinical and echocardiographic follow-up for mean 5.1 years.
Main Results:
- PPM incidence was 32%.
- PPM predicted recurrent heart failure and poor late survival (10-year survival: 65% with PPM vs. 75% without).
- PPM was not a predictor of postoperative pulmonary hypertension.
Conclusions:
- PPM is frequent after MVR and associated with adverse outcomes.
- Recurrent heart failure and reduced late survival are linked to PPM.
- Implanting appropriately sized prostheses is crucial for MVR patients.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Stenosis III: Medical Management

